These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


231 related items for PubMed ID: 3389377

  • 1. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J, Alvar J, Polo RM, González-Lahoz JM.
    Am J Med; 1988 Jul; 85(1):128. PubMed ID: 3389377
    [No Abstract] [Full Text] [Related]

  • 2. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G, Jama H, Ozsoylu S.
    Trans R Soc Trop Med Hyg; 1988 Jul; 82(3):417. PubMed ID: 3232176
    [No Abstract] [Full Text] [Related]

  • 3. Kala azar with disseminated dermal leishmaniasis.
    Kumar PV, Sadeghi E, Torabi S.
    Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of kala azar.
    Ozsoylu S.
    Lancet; 1996 Jun 15; 347(9016):1701. PubMed ID: 8642997
    [No Abstract] [Full Text] [Related]

  • 6. Low dose glucantime therapy in Leishmania viannia braziliensis (Lvb) infections.
    Costa JM, Marsden PD.
    Rev Soc Bras Med Trop; 1988 Jun 15; 21(2):85-6. PubMed ID: 3249826
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F, Pellizzer G, Gradoni L, Vespignani M, Franzetti M, Stecca C.
    Clin Infect Dis; 1993 May 15; 16(5):730-1. PubMed ID: 8507769
    [No Abstract] [Full Text] [Related]

  • 9. Chemotherapy of leishmaniasis in India.
    Thakur CP.
    Indian J Pediatr; 1987 May 15; 54(1):7-10. PubMed ID: 3030933
    [No Abstract] [Full Text] [Related]

  • 10. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
    Kuyucu N, Kara C, Bakirtaç A, Teziç T.
    Pediatr Infect Dis J; 2001 Apr 15; 20(4):455-7. PubMed ID: 11332679
    [Abstract] [Full Text] [Related]

  • 11. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
    Hueso M, Bover J, Serón D, Gil-Vernet S, Rufí G, Alsina J, Grinyó JM.
    Nephrol Dial Transplant; 1999 Dec 15; 14(12):2941-3. PubMed ID: 10570102
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
    Barthet M, Brunet P, Bernard JC, Dussol B, Rodor F, Jouglard J, Berland Y, Sahel J.
    Gastroenterol Clin Biol; 1994 Dec 15; 18(1):90-2. PubMed ID: 8187998
    [No Abstract] [Full Text] [Related]

  • 14. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
    Utili R, Rambaldi A, Tripodi MF, Andreana A.
    Infection; 1995 Dec 15; 23(3):182-3. PubMed ID: 7499009
    [Abstract] [Full Text] [Related]

  • 15. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C, Simon F, Dordain ML.
    Med Trop (Mars); 2000 Dec 15; 60(4):342-3. PubMed ID: 11436584
    [No Abstract] [Full Text] [Related]

  • 16. Visceral leishmaniasis in clinical practice.
    Davidson RN.
    J Infect; 1999 Sep 15; 39(2):112-6. PubMed ID: 10609527
    [No Abstract] [Full Text] [Related]

  • 17. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L, Mantovani MP, Gradoni L, Gramiccia M, Guandalini S.
    Trans R Soc Trop Med Hyg; 1990 Sep 15; 84(4):534-5. PubMed ID: 2091347
    [No Abstract] [Full Text] [Related]

  • 18. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
    Amusategui I, Sainz A, Tesouro MA.
    Ann N Y Acad Sci; 1998 Jun 29; 849():447-9. PubMed ID: 9668510
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.